← Back to Search

PREVENT tool for Cardiovascular Disease

N/A
Waitlist Available
Led By Maura Kepper, Ph.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 48 hours of clinic visit and at 3-months
Awards & highlights

Study Summary

This study is evaluating whether a new tool can help improve cardiovascular health for adolescents and young adults.

Eligible Conditions
  • Cardiovascular Disease
  • Young Adult Cancer Survivors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 48 hours of clinic visit and at 3-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 48 hours of clinic visit and at 3-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in body mass index (BMI)
Change in food intake behaviors
Change in minutes of physical activity
+1 more
Secondary outcome measures
Change in patient's cholesterol
Change in patient's fasting blood glucose
Change in patients' satisfaction of PREVENT tool: survey
+4 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: ProvidersExperimental Treatment1 Intervention
-All eligible providers will be sent questionnaires electronically to their email at baseline and follow-up. Providers will be invited to attend a training session to educate them on the PREVENT tool at baseline. The providers will be delivering the PREVENT tool.
Group II: Patients - PREVENT ToolExperimental Treatment1 Intervention
Complete questionnaires and accelerometry at baseline (administered electronically or by mail; accelerometers administered by mail). Following baseline measurement, patients will be randomized and attend their clinic visit. Follow-up measures will be administered 3-months and 6-months after the clinic visit electronically and by mail At the clinic visit, the provider will use PREVENT tool to discuss risk and deliver a tailored behavioral change plan inclusive of patient-centered community resources. PREVENT will calculate patient's overall risk for developing cardiovascular disease. Physical activity and food intake recommendations are tailored to current weight status and health behaviors using evidence-based recommendations.
Group III: Patients - Wait-List ControlActive Control1 Intervention
Complete questionnaires and accelerometry at baseline (administered electronically or by mail; accelerometers administered by mail). Following baseline measurement, patients will be randomized and attend their clinic visit. Follow-up measures will be administered 3-months and 6-months after the clinic visit electronically and by mail A PREVENT action plan (behavior change prescription, community resources, and education) will be provided to the patient via email after the completion of the follow-up measurement.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PREVENT tool
2020
N/A
~70

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,936 Previous Clinical Trials
2,299,664 Total Patients Enrolled
American Cancer Society, Inc.OTHER
224 Previous Clinical Trials
110,429 Total Patients Enrolled
Maura Kepper, Ph.D.Principal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
65 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Using Health Information Technology to Improve Health Behaviors and Promote Cardiovascular Health Among Adolescent and Young Adult Cancer Survivors
2021. "Using Health Information Technology to Improve Health Behaviors and Promote Cardiovascular Health Among Adolescent and Young Adult Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04623190.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top